Company No: 02349827 (England and Wales)

Contents

• Company Information
• Balance Sheet
• Notes to the Financial Statements

DIRECTORS	Paula Ann Carroll
	Peter Carroll
	Janet Elizabeth Noble
	Richard Noble

SECRETARIES	Paula Ann Carroll
	Richard Noble

REGISTERED OFFICE	Medezine Ltd Unit 11 Chambers Way
	Thorncliffe Business Park
	Chapeltown
	Sheffield
	S35 2PH
	United Kingdom

COMPANY NUMBER

02349827 (England and Wales)

ACCOUNTANT	Ian Walker & Co
	Wellington House
	Aviator Court
	Clifton Moor
	York
	YO30 5FD

	Note	2025		2024
		£		£
Fixed assets
Tangible assets	3	127,897		136,638
		127,897		136,638
Current assets
Stocks	4	189,368		177,005
Debtors	5	158,272		138,582
Cash at bank and in hand		151,705		168,369
		499,345		483,956
Creditors: amounts falling due within one year	6	( 198,229)		( 294,578)
Net current assets		301,116		189,378
Total assets less current liabilities		429,013		326,016
Creditors: amounts falling due after more than one year	7	0		( 14,941)
Net assets		429,013		311,075
Capital and reserves
Called-up share capital	8	103		103
Share premium account		7,485		7,485
Profit and loss account		421,425		303,487
Total shareholder's funds		429,013		311,075

For the financial year ending 30 September 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• The member has not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
• The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
• These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Income and Retained Earnings has not been delivered.

The financial statements of Medezine Limited (registered number: 02349827) were approved and authorised for issue by the Board of Directors on 23 April 2026. They were signed on its behalf by:

Richard Noble Director

Peter Carroll Director

1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Medezine Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Medezine Ltd Unit 11 Chambers Way, Thorncliffe Business Park, Chapeltown, Sheffield, S35 2PH, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Going concern

The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line or reducing balance basis over its expected useful life, as follows:

Leasehold improvements	5 years straight line
Plant and machinery	10 years straight line
Fixtures and fittings	3 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Borrowing costs

Borrowing costs that are directly attributable to acquisition, construction or production of qualifying assets, are capitalised as part of the cost of those assets. Capitalisation begins when both finance costs and expenditures for the asset are being incurred and activities that are necessary to get the asset ready for use are in progress. Capitalisation ceases when substantially all the activities that are necessary to get the asset ready for use are complete.

All other borrowing costs are recognised in profit or loss in the period in which they are incurred.

Leases

The Company as lessee
Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to the profit and loss account on a straight line basis over the period of the lease.

Impairment of assets

Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to sell, which is equivalent to the net realisable value. Cost includes materials, direct labour and an attributable proportion of manufacturing overheads based on normal levels of activity. Cost is calculated using the FIFO (first-in, first-out) method. Provision is made for obsolete, slow-moving or defective items where appropriate.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

2. Employees

	2025		2024
	Number		Number
Monthly average number of persons employed by the Company during the year, including directors	8		8

3. Tangible assets

	Leasehold improve- ments		Plant and machinery		Fixtures and fittings		Total
	£		£		£		£
Cost
At 01 October 2024	37,936		144,143		11,668		193,747
Additions	0		10,982		1,700		12,682
At 30 September 2025	37,936		155,125		13,368		206,429
Accumulated depreciation
At 01 October 2024	31,532		14,414		11,163		57,109
Charge for the financial year	6,074		14,860		489		21,423
At 30 September 2025	37,606		29,274		11,652		78,532
Net book value
At 30 September 2025	330		125,851		1,716		127,897
At 30 September 2024	6,404		129,729		505		136,638

4. Stocks

	2025		2024
	£		£
Finished goods	189,368		177,005

5. Debtors

	2025		2024
	£		£
Trade debtors	126,411		104,319
Other debtors	31,861		34,263
	158,272		138,582

6. Creditors: amounts falling due within one year

	2025		2024
	£		£
Bank loans	14,941		43,361
Trade creditors	74,870		145,583
Amounts owed to Parent undertakings	49,890		49,890
Taxation and social security	17,682		0
Other creditors	40,846		55,744
	198,229		294,578

7. Creditors: amounts falling due after more than one year

	2025		2024
	£		£
Bank loans	0		14,941

There are no amounts included above in respect of which any security has been given by the small entity.

8. Called-up share capital

	2025		2024
	£		£
Allotted, called-up and fully-paid
100 Ordinary shares of £ 1.00 each	100		100
1 Ordinary A share of £ 1.00	1		1
1 Ordinary B share of £ 1.00	1		1
1 Ordinary C share of £ 1.00	1		1
	103		103

9. Financial commitments

Commitments

Capital commitments are as follows:

	2025		2024
	£		£
Contracted for but not provided for:
Other	22,131		33,402

10. Ultimate controlling party

Parent Company:

Medezine Holdings Limited